bluebird bio, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | On November 3, 2021, the Issuer issued 23,368,988 shares of its common stock to its sole stockholder, bluebird bio, Inc. ("bluebird"). |
F2 | On November 4, 2021, bluebird distributed all of the issued and outstanding shares of the Issuer's common stock to its stockholders on a pro rata basis, with each bluebird stockholder receiving one share of the Issuer's common stock for every three shares of bluebird common stock, as part of the separation of the Issuer from bluebird into two independent public companies. |